Dr Rachel V Walden, MD | |
245 N Binkley St, Suite 101, Soldotna, AK 99669-7500 | |
(907) 714-4111 | |
Not Available |
Full Name | Dr Rachel V Walden |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 245 N Binkley St, Soldotna, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548299274 | NPI | - | NPPES |
M2493 | Other | TX | STATE MEDICAL LICENSE |
1638023 | Medicaid | AK | |
1769580-01 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080N0001X | Pediatrics - Neonatal-perinatal Medicine | M2493 (Texas) | Secondary |
208000000X | Pediatrics | M2493 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rachel V Walden, MD 250 Hospital Pl, Soldotna, AK 99669-7559 Ph: () - | Dr Rachel V Walden, MD 245 N Binkley St, Suite 101, Soldotna, AK 99669-7500 Ph: (907) 714-4111 |
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
CrystalGenomics, Inc., a biopharmaceutical company headquartered in Korea, has just announced positive results from the Phase 2b osteoarthritis (OA) study of the CG100649, CrystalGenomics' next-generation NSAID candidate.
For A Cause, has been organizing breast cancer fundraising walks since 2001. This Mother's Day, the unofficial start to the breast cancer walking season, tens of thousands of women will take to the streets to raise awareness and funds for breast cancer organizations.
Dyax Corp. announced today the publication of results from its second Phase 3, placebo-controlled trial, known as EDEMA4, evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema. The results, published in the June 2010 issue of the Annals of Allergy, Asthma, and Immunology, indicate that KALBITOR is effective in ameliorating HAE attacks, resolving associated symptoms and preventing attack progression.
› Verified 6 days ago
Mr. Alexander Brevard Russell, Jr, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 245 N Binkley St, Suite 101, Soldotna, AK 99669 Phone: 907-714-4111 Fax: 844-912-3953 | |
Dr. Carole Buchholz, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44455 Sterling Hwy, Soldotna, AK 99669 Phone: 907-262-2229 |